Literature DB >> 1707707

The antinociceptive activity of paracetamol in zymosan-induced peritonitis in mice: the role of prostacyclin and reactive oxygen species.

N S Doherty1, T H Beaver, K Y Chan, R J Dinerstein, K A Diekema.   

Abstract

1. Oral administration of high doses of paracetamol (600 mg kg-1 or more) resulted in inhibition of the writhing and reduced the levels of prostacyclin (PGI2, measured as 6-keto-PGF1 alpha) induced by intraperitoneal administration of zymosan in mice. The high oral doses of paracetamol required were accompanied by behavioural toxicity which may have contributed to the inhibition of writhing. 2. The number of writhes per mouse and the proportion of mice writhing at least once correlated significantly with the levels of 6-keto-PGF1 alpha. However, inhibition of writhing by paracetamol occurred at higher levels of 6-keto-PGF1 alpha than was previously observed with acidic non-steroidal anti-inflammatory agents. 3. When injected i.p., PGI2, carbacyclin and iloprost (agonists at the PGI2 receptor) induced writhing. Intraperitoneal injection of PGI2 reversed the inhibition of writhing induced by indomethacin (1 mg kg-1, p.o.) but not that induced by oral administration of paracetamol. 4. Paracetamol at 800 mg kg-1, p.o., inhibited carbacyclin-induced writhing but indomethacin at 1 mg kg-1 p.o. did not. Paracetamol administered i.p. at 100 mg kg-1 reduced the peritoneal levels of 6-keto-PGF1 alpha and inhibited zymosan-induced but not carbacyclin-induced writhing and did not produce behavioural toxicity. 5. The in vitro potency of paracetamol as a prostaglandin synthesis inhibitor is known to be reduced by the presence of lipid peroxides. However, no lipid peroxides, measured as thiobarbituric acid reactive material, were detected in the peritoneal lavage fluid of zymosan-injected mice. 6. Intraperitoneal administration of a mixture of superoxide dismutase and catalase reduced detectable superoxide anion by 98% without inhibiting the writhing response to zymosan or the antinociceptive potency of paracetamol. 7. The data are consistent with the suggestion that inhibition of PGI2 synthesis in the peritoneal cavity by paracetamol is responsible for only a part of its antinociceptive activity in this test. However, extremely high oral doses of paracetamol were required which produced behavioural toxicity which clearly contributed to the inhibition of writhing. The low potency of paracetamol in this model cannot be attributed to the generation of lipid peroxides via the oxidative burst.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1707707      PMCID: PMC1917824          DOI: 10.1111/j.1476-5381.1990.tb14173.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  In vitro formation of activators for prostaglandin synthesis by neutrophils and macrophages from humans and guinea pigs.

Authors:  P J Marshall; W E Lands
Journal:  J Lab Clin Med       Date:  1986-12

2.  Indomethacin blocks central nociceptive effects of PGF2 alpha.

Authors:  Y O Taiwo; J D Levine
Journal:  Brain Res       Date:  1986-05-14       Impact factor: 3.252

3.  Pharmacology of free radicals; recent views on their relation to inflammatory mechanisms.

Authors:  F Hertz; A Cloarec
Journal:  Life Sci       Date:  1984-02-20       Impact factor: 5.037

4.  Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2.

Authors:  N S Doherty; P Poubelle; P Borgeat; T H Beaver; G L Westrich; N L Schrader
Journal:  Prostaglandins       Date:  1985-11

5.  Hyperalgesic action in mice of intracerebroventricularly administered arachidonic acid, PG E2, PG F2 alpha and PG D2: effects of analgesic drugs on hyperalgesia.

Authors:  S Okuyama; H Aihara
Journal:  J Pharmacobiodyn       Date:  1986-11

6.  Hyperalgesic action in rats of intracerebroventricularly administered arachidonic acid, PG E2 and PG F2 alpha: effects of analgesic drugs on hyperalgesia.

Authors:  S Okuyama; H Aihara
Journal:  Arch Int Pharmacodyn Ther       Date:  1985-11

7.  Site of analgesic action of a non-steroidal, anti-inflammatory drug, tolmetin sodium, in rats.

Authors:  H Nakamura; M Shimizu
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

8.  Paracetamol, 3-monoalkyl- and 3,5-dialkyl-substituted derivatives. Antioxidant activity and relationship between lipid peroxidation and cytotoxicity.

Authors:  R van de Straat; G J Bijloo; N P Vermeulen
Journal:  Biochem Pharmacol       Date:  1988-09-15       Impact factor: 5.858

9.  Effect of carrageenin-induced pedal edema on rat brain prostaglandins.

Authors:  S K Bhattacharya; N Das
Journal:  Neurochem Pathol       Date:  1984

10.  Alterations in nociception after intracisternal administration of prostaglandin D2, E2 or F2 alpha to conscious mice.

Authors:  S Horiguchi; R Ueno; M Hyodo; O Hayaishi
Journal:  Eur J Pharmacol       Date:  1986-03-18       Impact factor: 4.432

View more
  3 in total

1.  Post-capillary venules in the "milky spots" of the greater omentum are the major site of plasma protein and leukocyte extravasation in rodent models of peritonitis.

Authors:  N S Doherty; R J Griffiths; J P Hakkinen; D N Scampoli; A J Milici
Journal:  Inflamm Res       Date:  1995-04       Impact factor: 4.575

2.  Beneficial effects of Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in zymosan-induced shock.

Authors:  S Cuzzocrea; G Costantino; E Mazzon; A De Sarro; A P Caputi
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

3.  Nitroparacetamol exhibits anti-inflammatory and anti-nociceptive activity.

Authors:  O A al-Swayeh; L E Futter; R H Clifford; P K Moore
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.